Tax compliance is critical and a large number of drug dealers will be investigated

"Pharmaceutical network industry dynamics" with the two-vote system, the national volume of procurement, not only regulate the circulation of drugs in the pharmaceutical industry, but also make pharmaceutical enterprises tax compliance requirements continue to improve.
October 22, the Inner Mongolia Autonomous Region Pharmaceutical Procurement Network issued a "notice on the convening of an interview on the transfer of drug procurement bills."
notice shows that according to the Notice on the Timely Upload and Correction of Drug Invoice Information (No. 78 of the Internal Medicines Center (2020).
after many urgings, some enterprises have not fully uploaded invoice information and upload information errors have not been corrected in place, so after research, the Inner Mongolia Autonomous Region Pharmaceutical Procurement Network decided to convene a drug procurement bill transmission interview.
meeting was held on October 27, 2020, and the participants were 1 person in charge of each distribution company, involving a total of 22 pharmaceutical commercial companies.
the whole country, in addition to the Inner Mongolia Autonomous Region, at present, all over the country are stepping up the investigation and punishment of false inding.
example, the Jilin Provincial Tax Bureau website issued a notice that the two pharmaceutical companies have abnormal financial flows, the two companies were determined to belong to the "shell company", specifically illegal false insanity.
July 15, Guangdong Province announced a number of cases involving pharmaceutical companies suspected of falsely opening special VAT invoices, as many as seven cases, and on July 3, Shenzhen announced as many as 13 cases of pharmaceutical enterprises suspected of falsely opening special VAT invoices.
addition, since this year, Hainan, Henan, Hubei, Sichuan, Hunan, Qingdao and other provinces and cities have also a number of pharmaceutical enterprises suspected of falsely opening special VAT invoices were punished.
cases involving false VAT invoices, involving taxes ranged from several thousand yuan to tens of millions of yuan, most of them in the millions.
, according to industry insiders, with the gradual landing of the two-vote system, its impact on the pharmaceutical industry is gradually emerging.
in recent years, many listed pharmaceutical companies in the annual report said that with the implementation of the two-vote system and other policies, the company is facing repayment, product promotion problems.
In fact, after the formal implementation of the two-vote system, false insaling, tax evasion and other tax-related violations have become the focus of efforts to correct the field of pharmaceutical purchase and sale and medical services in the wrong wind, the State Administration of Taxation has also launched a series of local rectification work for the pharmaceutical industry.
in 2016, it is clear that the pharmaceutical enterprises should carry out special rectification of tax-related issues, crack down on illegal acts such as false invoding and tax evasion, and investigate and punish a number of cases involving tax violations; "False tax invoices; for wholesale enterprise operators, focus on combating malicious cooperation with production enterprises "over-ticket money laundering"; in 2019, to combat tax-related illegal acts such as false invoicing in the pharmaceutical industry; and to increase the inspection and processing of invoices and use of pharmaceutical and consumables production and operation units, and to strictly investigate false invoicing.
, the pharmaceutical industry is still stepping up tax inspection efforts to improve tax compliance.
At the National Tax Work Conference held in Beijing on January 6 this year, the relevant departments made it clear that this year will continue to improve the tax big data and risk management mechanism, "anti-fight combination" in accordance with the law to severely crack down on the use of "fake enterprises" "fake exports" false tax fraud.
5, the State Health Insurance Administration issued the Guidance on the Establishment of a Credit Evaluation System for Pharmaceutical Prices and Recruitment (Draft for Comments).
The guidance proposes that a list of medical prices and the list of matters of breach of trust will be established, including, but not limited to, commercial bribery of pharmaceuticals, manipulation of market prices, breach of contract, disruption of procurement order and other illegal and illegal acts, contrary to good faith and fair competition.
above, the pharmaceutical industry will be more and more stringent tax, false insaling, etc. is still the focus of the fight against tax-related crimes.
addition, the production and sales of enterprises will be more and more transparent, while the illegal costs of related enterprises will be higher and higher.
the future, pharmaceutical companies can only go further if they are compliant in fiscal and taxation.
and for those pharmaceutical companies that do not meet the tax standards, the future will be difficult without early transformation.